Credelio For Dogs 12 To 25 Lbs (225mg) Orange 6 Doses

What is Credelio For Dogs 12 To 25 Lbs (225mg) Orange 6 Doses?

Credelio For Dogs 12 To 25 Lbs (225mg) Orange 6 Doses is a veterinarian-recommended, chewable tablet designed to kill fleas and control tick infestations in dogs. Each orange tablet contains 225mg of lotilaner, an active ingredient that begins killing fleas within four hours and achieves over 99% effectiveness within 12 hours. This 6-dose pack provides six months of continuous monthly protection for dogs weighing between 12 and 25 pounds. Manufactured by Elanco, Credelio is FDA-approved and suitable for dogs 8 weeks of age and older.

Key features

• Fast-acting formula — kills fleas within 4 hours and ticks within 8 hours.
• Monthly protection — one dose provides full month coverage against fleas and ticks.
• Chewable tablet — palatable orange chew, easy to administer with or without food.
• Broad tick control — effective against black-legged, American dog, lone star, and brown dog ticks.
• Safe for puppies — approved for dogs 8 weeks and older weighing 12–25 lbs.
• FDA-approved — backed by clinical studies and veterinary use.
• 6-month supply — includes six individually packaged doses for consistent dosing.

Who is Credelio For Dogs 12 To 25 Lbs (225mg) Orange 6 Doses for?

This product is ideal for dog owners seeking a reliable, oral flea and tick solution for small to medium-sized breeds. It’s especially beneficial for pets that dislike topical treatments or live in high-risk tick areas. Veterinarians often recommend Credelio for dogs with flea allergy dermatitis or those needing consistent, month-round parasite prevention. It’s not intended for cats or dogs under 12 lbs.

How does Credelio For Dogs 12 To 25 Lbs (225mg) Orange 6 Doses compare?

Compared to topical treatments, Credelio offers a mess-free, odorless alternative that doesn’t transfer to humans or furniture. Unlike some oral competitors, it starts killing fleas faster—within four hours—and maintains efficacy throughout the month. While similar in active ingredient class to NexGard, Credelio has demonstrated comparable or superior tick control in clinical trials. It’s more expensive than generic alternatives but offers branded reliability and consistent performance.